This presentation primary aim is to discuss how a holistic, life cycle management approach should be applied to the design of facilities and product supply models to meet the difficult predictable future demands for pharmaceuticals from the marked.
The presentation includes discussion of several new trends in design of Biomanufacturing plants, which include increased focus on the logistics supporting the core production processes. This include the organisation, training and collaboration of the staff, as well as the level of automation and implementation of robotics.
Additionally, the presentation will cover the implication this reality has on manufacturing strategies, cost implications with focus on the development of new technologies.
Options for incorporating flexibility in the conceptual design phase
Include the future operating model of the final facility in the facility design
Selection of the “righttechnologies” – balance the use of proven and new technologies
Speaker: Morten Munk | Global Technology Partner, NNE
Morten Munk’s career is comprised of 30 years of experience within the global biopharmaceutical industry.
One common denominator for his work has been to ensure a holistic and broad perspective on biomanufacturing challenges from idea to establish facilities. His key focus is to ensure compliant and cost-effective production through the optimal use of all relevant and available knowledge and technologies, such as single-use systems and continuous processing.
He combines his technological expertise with a thorough business understanding coupled with a great personal interest in and practice understanding of stakeholder relations and change management.
Morten joined NNE as Global Technology Partner in 2015. In 2001 he co-founded CMC Biologics, after working 14 years at Novo Nordisk.